It was reported to boston scientific corporation that a spaceoar vue device was implanted during a spaceoar vue placement procedure in (b)(3) 2023.The procedure was performed with local anesthesia, after the placement the successful injection was confirmed via ultrasound.On (b)(3) 2023, the patient experienced a non-serious infection, increased pulse rate and rectal pain, it was also noted that after the procedure the patient had high temperature.The event of infection it was resolved with antibiotics and co-amoxiclav for management of the possible infection that at the same time helped with the increased pulse.The high temperature was addressed with medication for fever.The rectal pain was treated with ibuprofen.The patient current condition was unknown.However, the adverse events were reported as resolved on (b)(3)2023.
|